Pipeline

Two clinically advanced platforms to fight blood cancers and solid tumors

Two platforms drive next-generation immunotherapies

We are developing and implementing two immuno-oncology platform technologies designed to harness the immune system by employing novel, controlled gene expression and innovative cell engineering technologies to deliver safe, effective, and scalable cell- and viral-based therapies for the treatment of multiple cancer types.